Grant: Discovery Grants Program - Individual
Université de Montréal
$58,000.00
Programmable DNA-based switches and nanomachines for sensing and drug delivery applications
FY 2024-25
Summary
Over the course of millions of years, living organisms have developed ingenious "nanomachines": entities that act like "green" technology on the scale of a nanometer (one-millionth of a millimetre). These nanoscopic machines allow an organism to produce and store clean energy, as well as create molecular systems that detect and protect it from toxic substances, tumors, viruses and bacteria. Dr. Vallée-Bélisle wants to reveal the secrets behind these nanomachines, opening the door to the creation of revolutionary nanotechnologies that could have a major impact on global health and the environment.
Dr. Vallée-Bélisle's research program aims at integrating research efforts from various scientific fields (chemistry, biochemistry, electrical and biomedical engineering, and medicine) to develop bio-nanotechnologies that will have an unprecedented impact on global health. More specifically, his laboratory will continue to characterize the mechanisms of natural nanomachines by exploring the thermodynamic and kinetic basis of various of its activation/regulation mechanisms (PROJECT I). This work aims to understand nanomachines via a "synthetic biology" approach by recreating them using DNA chemistry, a highly "programmable" polymers. These fundamental studies provide the basic rules for the design of efficient artificial nanomachines. Other specific objectives of this discovery grant include the design of a wide variety of artificial DNA switches and nanomachines for molecular sensing and medical diagnosis (PROJECT II) as well as programmable nanomachines for targeted drug delivery (chemotherapy or gene therapy) (PROJECT III), which enable improved treatments with reduced side effects.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-06975
Name nom
Vallée-Bélisle, Alexis
Department département
Chimie - Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
58000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Programmable DNA-based switches and nanomachines for sensing and drug delivery applications
Keywords
dna nanotechnology; nanomachines and biosensors; molecular switches; thermodynamics, kinetics; mechanisms; allostery, pre-association; drug delivery systems; point-of-care sensors; cooperatively; fluorescence, electrochemistry
Application summary
Over the course of millions of years, living organisms have developed ingenious "nanomachines": entities that act like "green" technology on the scale of a nanometer (one-millionth of a millimetre). These nanoscopic machines allow an organism to produce and store clean energy, as well as create molecular systems that detect and protect it from toxic substances, tumors, viruses and bacteria. Dr. Vallée-Bélisle wants to reveal the secrets behind these nanomachines, opening the door to the creation of revolutionary nanotechnologies that could have a major impact on global health and the environment.
Dr. Vallée-Bélisle's research program aims at integrating research efforts from various scientific fields (chemistry, biochemistry, electrical and biomedical engineering, and medicine) to develop bio-nanotechnologies that will have an unprecedented impact on global health. More specifically, his laboratory will continue to characterize the mechanisms of natural nanomachines by exploring the thermodynamic and kinetic basis of various of its activation/regulation mechanisms (PROJECT I). This work aims to understand nanomachines via a "synthetic biology" approach by recreating them using DNA chemistry, a highly "programmable" polymers. These fundamental studies provide the basic rules for the design of efficient artificial nanomachines. Other specific objectives of this discovery grant include the design of a wide variety of artificial DNA switches and nanomachines for molecular sensing and medical diagnosis (PROJECT II) as well as programmable nanomachines for targeted drug delivery (chemotherapy or gene therapy) (PROJECT III), which enable improved treatments with reduced side effects.